KineMed Broadens Collaboration with Bristol-Myers Squibb

Kinemed, a company developing treatments and a biomarker for ALS, and Bristol-Myers Squibb will be broadening their collaboration in the area of neurodegenerative diseases.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail